Get started
Author

Chantal Campello

Observed names: C Campello, C. Campello, C. Campello Md, C.H. Campello, CAMPELLO, Chantal, CHANTAL CAMPELLO, Campello Chantal
Observed institutions: Centre National de la Recherche Scientifique, Inserm, Aix-Marseille Université, Sorbonne Université, Assistance Publique Hôpitaux de Marseille, Centre Hospitalier Universitaire de Montpellier, Centre de Recherche en Neurosciences de Lyon, Assistance Publique – Hôpitaux de Paris, Institut de Neurophysiopathologie, Hospices Civils de Lyon, Centre Hospitalier Universitaire de Nîmes, Hôpital Pierre Wertheimer, Pitié-Salpêtrière Hospital, Centre Hospitalier Le Vinatier, Association des Neuro-Oncologues d’Expression Française, Institut du Cerveau, Hôpital de la Timone, Université Pierre-et-Marie-Curie
OpenAlex ID: A5113535233
Management and outcome of primary CNS lymphoma in the modern era
2020 · Caroline Houillier, Carole Soussain, et al. · Neurology · 247
Temozolomide in Elderly Patients With Newly Diagnosed Glioblastoma and Poor Performance Status: An ANOCEF Phase II Trial
2011 · Jaime Gállego Pérez-Larraya, François Ducray, et al. · Journal of Clinical Oncology · 212
PDF
Oncological patterns of care and outcome for 952 patients with newly diagnosed glioblastoma in 2004
2010 · L. Bauchet, H. Mathieu-Daude, et al. · Neuro-Oncology · 185
PDF
French brain tumor data bank: Methodology and first results on 10,000 cases
2007 · Luc Bauchet, Valérie Rigau, et al. · Journal of Neuro-Oncology · 147
Everolimus and Octreotide for Patients with Recurrent Meningioma: Results from the Phase II CEVOREM Trial
2020 · Thomas Graillon, Marc Sanson, et al. · Clinical Cancer Research · 144
Combination of neoadjuvant chemotherapy followed by surgical resection as a new strategy for WHO grade II gliomas: a study of cognitive status and quality of life
2011 · Marie Blonski, Luc Taillandier, et al. · Journal of Neuro-Oncology · 102
Randomized phase II trial of irinotecan and bevacizumab as neo-adjuvant and adjuvant to temozolomide-based chemoradiation compared with temozolomide-chemoradiation for unresectable glioblastoma: final results of the TEMAVIR study from ANOCEF
2014 · B. Chauffert, L. Feuvret, et al. · Annals of Oncology · 96
Coping strategies and quality of life: a longitudinal study of high-grade glioma patient-caregiver dyads
2018 · Karine Baumstarck, Olivier Chinot, et al. · Health and Quality of Life Outcomes · 70
PDF
Contrast enhancement in 1p/19q-codeleted anaplastic oligodendrogliomas is associated with 9p loss, genomic instability, and angiogenic gene expression
2013 · German Reyes-Botero, Caroline Dehais, et al. · Neuro-Oncology · 69
Mitotic index, microvascular proliferation, and necrosis define 3 groups of 1p/19q codeleted anaplastic oligodendrogliomas associated with different genomic alterations
2014 · D. Figarella-Branger, K. Mokhtari, et al. · Neuro-Oncology · 63
PDF
First Results of the Acsé Pembrolizumab Phase II in the Primary CNS Lymphoma (PCNSL) Cohort
2020 · Khe Hoang-Xuan, Roch Houot, et al. · Blood · 58
Thalamic Lesions: A Radiological Review
2014 · Dimitri Renard, Giovanni Castelnovo, et al. · Behavioural Neurology · 55
PDF
An MRI review of acquired corpus callosum lesions
2014 · D. Renard, G. Castelnovo, et al. · Journal of Neurology Neurosurgery & Psychiatry · 48
Temozolomide Plus Bevacizumab in Elderly Patients with Newly Diagnosed Glioblastoma and Poor Performance Status: An ANOCEF Phase II Trial (ATAG)
2018 · Germán Reyes-Botero, Stéphanie Cartalat-Carel, et al. · The Oncologist · 37
Coping with a newly diagnosed high-grade glioma: patient-caregiver dyad effects on quality of life
2016 · K. Baumstarck, T. Leroy, et al. · Journal of Neuro-Oncology · 34
Ongoing Clinical Trials
2010 · J. L. Clarke, M. M. Ennis, et al. · Neuro-Oncology · 22
PDF
Prognostic value of health‐related quality of life for death risk stratification in patients with unresectable glioblastoma
2016 · Brice Paquette, Dewi Vernerey, et al. · Cancer Medicine · 19
PDF
Challenges in diagnosis and management of adult spinal cord gliomas
2021 · C. Campello, E. Tabouret, et al. · Revue Neurologique · 17
A genome-wide association study identifies susceptibility loci for primary central nervous system lymphoma at 6p25.3 and 3p22.1: a LOC Network study
2019 · Karim Labreche, Mailys Daniau, et al. · Neuro-Oncology · 16
PDF
Temozolomide plus bevacizumab in elderly patients with newly diagnosed glioblastoma and poor performance status: An Anocef phase II trial.
2013 · German Reyes-Botero, Jerôme Honnorat, et al. · Journal of Clinical Oncology · 16
The 20210A Allele of the Prothrombin Gene Is Frequent in Young Women With Unexplained Spinal Cord Infarction
1998 · Eric Mercier, Isabelle Quere, et al. · Blood · 16
Primary Brain Amyloidoma
2008 · Dimitri Renard, Chantal Campello, et al. · Archives of Neurology · 15
Leptomeningeal Gliomatosis: A Single Institution Study of 31 Patients
2019 · DIDIER AUTRAN, MARYLINE BARRIE, et al. · Anticancer Research · 14
PDF
Relationship between magnetic resonance imaging characteristics and plasmatic levels of MMP2 and MMP9 in patients with recurrent high-grade gliomas treated by Bevacizumab and Irinotecan
2017 · Patrizia Farina, Emeline Tabouret, et al. · Journal of Neuro-Oncology · 14
Astrocytomes intramédullaires : analyse rétrospective française multicentrique
2017 · F. Parker, C. Campello, et al. · Neurochirurgie · 13
Works count: 106
Citation count: 1,870
H-index: 17
I10-index: 29
Year
Topic
Type